Works in Cancer Chemotherapy & Pharmacology, 2016, Vol 78, Issue 2

Results: 26

Evaluation of a method for calculating carboplatin dosage in DeVIC ± R therapy (combination therapy of dexamethasone, etoposide, ifosfamide and carboplatin with or without rituximab) as a salvage therapy in patients with relapsed or refractory non-Hodgkin lymphoma.
Published in:
2016
By:
- Tomono, Ayana;
- Ito, Kaori;
- Hayashi, Takahiro;
- Ando, Maiko;
- Ando, Yosuke;
- Tsuge, Masahiro;
- Okamoto, Akinao;
- Inaguma, Yoko;
- Okamoto, Masataka;
- Emi, Nobuhiko;
- Yamada, Shigeki
Publication type:
journal article
Population pharmacokinetics of bevacizumab in cancer patients with external validation.
Published in:
2016
By:
- Han, Kelong;
- Peyret, Thomas;
- Marchand, Mathilde;
- Quartino, Angelica;
- Gosselin, Nathalie;
- Girish, Sandhya;
- Allison, David;
- Jin, Jin;
- Gosselin, Nathalie H;
- Allison, David E
Publication type:
journal article
Identifying novel therapeutic agents using xenograft models of pediatric cancer.
Published in:
2016
By:
- Kurmasheva, Raushan;
- Houghton, Peter;
- Kurmasheva, Raushan T;
- Houghton, Peter J
Publication type:
journal article
Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patients.
Published in:
2016
By:
- Zou, Ting;
- Yin, Jiye;
- Zheng, Wei;
- Xiao, Ling;
- Tan, Liming;
- Chen, Juan;
- Wang, Ying;
- Li, Xiangping;
- Qian, Chenyue;
- Cui, Jiajia;
- Zhang, Wei;
- Zhou, Honghao;
- Liu, Zhaoqian
Publication type:
journal article
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.
Published in:
2016
By:
- Smith, David;
- Powderly, John;
- Lee, James;
- Shepard, Dale;
- Wallin, Johan;
- Chaudhary, Archana;
- Chao, Grace;
- Ng, Wee;
- Mitchell, Malcolm;
- Grau, Gerrit;
- Kurek, Raffael;
- LoRusso, Patricia;
- Smith, David C;
- Lee, James J;
- Shepard, Dale R;
- Chao, Grace Yi;
- Ng, Wee Teck;
- Mitchell, Malcolm I
Publication type:
journal article
Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma.
Published in:
2016
By:
- Kahen, Elliot;
- Yu, Diana;
- Harrison, Douglas;
- Clark, Justine;
- Hingorani, Pooja;
- Cubitt, Christopher;
- Reed, Damon;
- Harrison, Douglas J;
- Cubitt, Christopher L;
- Reed, Damon R
Publication type:
journal article
High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
Published in:
2016
By:
- Jiang, Lin;
- Wang, Wenchao;
- Li, Guoli;
- Sun, Canlin;
- Ren, Zhenqin;
- Sheng, Haihui;
- Gao, Hengjun;
- Wang, Chaofu;
- Yu, Hong
Publication type:
journal article
A Phase I study of safety and pharmacokinetics of fruquintinib, a novel selective inhibitor of vascular endothelial growth factor receptor-1, -2, and -3 tyrosine kinases in Chinese patients with advanced solid tumors.
Published in:
2016
By:
- Cao, Junning;
- Zhang, Jian;
- Peng, Wei;
- Chen, Zhiyu;
- Fan, Songhua;
- Su, Weiguo;
- Li, Ke;
- Li, Jin
Publication type:
journal article
Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.
Published in:
2016
By:
- Hata, Tsuyoshi;
- Kudo, Toshihiro;
- Sakai, Daisuke;
- Takahashi, Hidekazu;
- Haraguchi, Naotsugu;
- Nishimura, Junichi;
- Hata, Taishi;
- Mizushima, Tsunekazu;
- Yamamoto, Hirofumi;
- Doki, Yuichiro;
- Mori, Masaki;
- Satoh, Taroh
Publication type:
journal article
Anti-VEGF and anti-EGFR agents open up new horizons changing the landscape for their associations.
Published in:
2016
By:
- Milano, Gerard
Publication type:
Letter
Response from Drs. Formica/Zaniboni to Dr. Milano.
Published in:
2016
By:
- Formica, V.;
- Zaniboni, A.
Publication type:
Letter
Population pharmacokinetics of Reditux™, a biosimilar Rituximab, in diffuse large B-cell lymphoma.
Published in:
2016
By:
- Gota, Vikram;
- Karanam, Ashwin;
- Rath, Sanhita;
- Yadav, Akanksha;
- Tembhare, Prashant;
- Subramanian, P.;
- Sengar, Manju;
- Nair, Reena;
- Menon, Hari
Publication type:
journal article
Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.
Published in:
2016
By:
- Bodnar, Lubomir;
- Stec, Rafał;
- Dzierżanowska, Małgorzata;
- Synowiec, Agnieszka;
- Cierniak, Szczepan;
- Kade, Grzegorz;
- Szczylik, Cezary;
- Stec, Rafał;
- Dzierżanowska, Małgorzata
Publication type:
journal article
Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer.
Published in:
2016
By:
- Fujiwara, Yutaka;
- Tamura, Kenji;
- Kondo, Shunsuke;
- Tanabe, Yuko;
- Iwasa, Satoru;
- Shimomura, Akihiko;
- Kitano, Shigehisa;
- Ogasawara, Ken;
- Turner, P.;
- Mori, Joji;
- Asou, Hiroya;
- Chan, Edward;
- Yamamoto, Noboru;
- Turner, P Kellie;
- Chan, Edward Michael
Publication type:
journal article
New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma.
Published in:
2016
By:
- Teuma, Cécile;
- Perier-Muzet, Marie;
- Pelletier, Solenne;
- Nouvier, Mathilde;
- Amini-Adl, Mona;
- Dijoud, Frédérique;
- Duru, Gérard;
- Thomas, Luc;
- Fouque, Denis;
- Laville, Maurice;
- Dalle, Stéphane;
- Teuma, Cécile;
- Dijoud, Frédérique;
- Duru, Gérard;
- Dalle, Stéphane
Publication type:
journal article
Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib.
Published in:
2016
By:
- Lam, Lisa;
- Capparelli, Edmund;
- Kurzrock, Razelle;
- Lam, Lisa H;
- Capparelli, Edmund V
Publication type:
journal article
TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer.
Published in:
2016
By:
- Ferraro, D.;
- Goldstein, D.;
- O'Connell, R.;
- Zalcberg, J.;
- Sjoquist, K.;
- Tebbutt, N.;
- Grimison, P.;
- McLachlan, S.;
- Lipton, L.;
- Vasey, P.;
- Gebski, V.;
- Aiken, C.;
- Cronk, M.;
- Ng, S.;
- Karapetis, C.;
- Shannon, J.;
- O'Connell, R L;
- Zalcberg, J R;
- Sjoquist, K M;
- Tebbutt, N C
Publication type:
journal article
A phase 1, dose-finding and pharmacokinetic study of gemcitabine with nab-paclitaxel in patients with metastatic breast cancer.
Published in:
2016
By:
- Yoshitomi, Seiji;
- Taira, Naruto;
- Doihara, Hiroyoshi;
- Mizoo, Taeko;
- Nogami, Tomohiro;
- Iwamoto, Takayuki;
- Motoki, Takayuki;
- Shien, Tadahiko;
- Ogasawara, Yutaka;
- Matsuoka, Junji;
- Tsuji, Hisashi;
- Mitsuhashi, Toshiharu
Publication type:
journal article
A phase II study of nanoparticle albumin-bound paclitaxel plus carboplatin as the first-line therapy in elderly patients with previously untreated advanced non-small cell lung cancer.
Published in:
2016
By:
- Okuma, Yusuke;
- Hosomi, Yukio;
- Takahashi, Satoshi;
- Nakahara, Yoshiro;
- Watanabe, Kageaki;
- Nagamata, Makoto;
- Takagi, Yusuke;
- Mikura, Shinichiro
Publication type:
journal article
Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features.
Published in:
2016
By:
- Kim, Jwa;
- Park, Inkeun;
- Lee, Jae;
- Kim, Jwa Hoon;
- Lee, Jae Lyun
Publication type:
journal article
Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG).
Published in:
2016
By:
- Matikas, A.;
- Kentepozidis, Ν.;
- Ardavanis, A.;
- Vaslamatzis, M.;
- Polyzos, A.;
- Emmanouilides, Ch.;
- Katsaounis, P.;
- Koinis, F.;
- Xynogalos, S.;
- Christopoulou, A.;
- Ziras, N.;
- Tegos, Th.;
- Prinarakis, E.;
- Hatzidaki, D.;
- Georgoulias, V.;
- Kotsakis, A.;
- Kentepozidis, Ν;
- HORG’s Lung Cancer Working Group
Publication type:
journal article
A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors.
Published in:
2016
By:
- Mross, Klaus;
- Richly, Heike;
- Frost, Annette;
- Scharr, Dirk;
- Nokay, Bahar;
- Graeser, Ralph;
- Lee, Chooi;
- Hilbert, James;
- Goeldner, Rainer-George;
- Fietz, Oliver;
- Scheulen, Max;
- Scheulen, Max E
Publication type:
journal article
Panitumumab in combination with irinotecan plus S-1 (IRIS) as second-line therapy for metastatic colorectal cancer.
Published in:
2016
By:
- Takaoka, Toshi;
- Kimura, Tetsuo;
- Shimoyama, Rai;
- Kawamoto, Shunji;
- Sakamoto, Kazuki;
- Goda, Fuminori;
- Miyamoto, Hiroshi;
- Negoro, Yuji;
- Tsuji, Akihito;
- Yoshizaki, Koji;
- Goji, Takahiro;
- Kitamura, Shinji;
- Yano, Hiromi;
- Okamoto, Koichi;
- Kimura, Masako;
- Okahisa, Toshiya;
- Muguruma, Naoki;
- Niitsu, Yoshiro;
- Takayama, Tetsuji
Publication type:
journal article
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations.
Published in:
2016
By:
- Mizoguchi, Kosuke;
- Nakamura, Yoichi;
- Sano, Kazumi;
- Sato, Shuntaro;
- Ikegami, Yoji;
- Motoshima, Kohei;
- Takemoto, Shinnosuke;
- Ogawara, Daiki;
- Senju, Hiroaki;
- Sugasaki, Nanae;
- Ikeda, Takaya;
- Yamaguchi, Hiroyuki;
- Nakatomi, Katsumi;
- Fukuda, Minoru;
- Izumikawa, Koichi;
- Mukae, Hiroshi
Publication type:
journal article
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.
Published in:
2016
By:
- Chow, Laura;
- Smith, David;
- Tan, Antoinette;
- Denlinger, Crystal;
- Wang, Ding;
- Shepard, Dale;
- Chaudhary, Archana;
- Lin, Yong;
- Gao, Ling;
- Chow, Laura Q M;
- Smith, David C;
- Tan, Antoinette R;
- Denlinger, Crystal S;
- Shepard, Dale R
Publication type:
journal article
The Best. First. Anti-EGFR before anti-VEGF, in the first-line treatment of RAS wild-type metastatic colorectal cancer: from bench to bedside.
Published in:
2016
By:
- Zaniboni, A.;
- Formica, V.
Publication type:
journal article